H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-07-26 AccNo: 0001144204-18-040208 Size: 38 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-07-26 AccNo: 0001144204-18-040206 Size: 1 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-07-26 AccNo: 0001144204-18-040208 Size: 38 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-07-26 AccNo: 0001144204-18-040206 Size: 1 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-07-26 AccNo: 0001144204-18-040208 Size: 38 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-07-26 AccNo: 0001144204-18-040206 Size: 1 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-07-10 AccNo: 0001144204-18-037797 Size: 48 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-06-29 AccNo: 0001144204-18-036585 Size: 48 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-06-15,COO,Capponi Vincent ,卖出,8633普通股, $12.00
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-06-14,COO,Capponi Vincent ,卖出,11367普通股, $12.00